Safety first, but pharmacy would support Cialis OTC switch

摘要

PHARMACY leaders would not object to a switch in status for the erectile dysfunction drug Cialis (tadalafil) from prescription-only to pharmacy, but insist that user safety would have to be paramount in regulatory approval for the change. The manufacturer of the drug, Lilly, has agreed a deal with Sanofi to allow the French firm to buy exclusive rights to apply to sell Cialis as a non-prescription medicine in Europe, the US, Canada and Australia after certain patents expire.